Torley Helen's Form 4 filing
Halozyme Therapeutics, Inc. (HALO) · filed Jun 24, 2025
- Accession no.
- 0001415889-25-018118
- Filed
- Jun 24, 2025
- Trade date
- Jun 20-24, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 3 derivative transactions. Open-market sales total $3.19M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Torley HelenCIK 0001528185 | Director, Officer (PRESIDENT AND CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $8.11 | +$162,200 | 753,719 | Direct | |
| Jun 20, 2025 | Common Stock | SSaleDisposed | −20,000 | $52.96 | −$1,059,200 | 733,719 | Direct | |
| Jun 23, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $8.11 | +$162,200 | 753,719 | Direct | |
| Jun 23, 2025 | Common Stock | SSaleDisposed | −20,000 | $52.57 | −$1,051,400 | 733,719 | Direct | |
| Jun 24, 2025 | Common Stock | MOption exerciseAcquired | +20,000 | $8.11 | +$162,200 | 753,719 | Direct | |
| Jun 24, 2025 | Common Stock | SSaleDisposed | −4,489 | $53.11 | −$238,410.79 | 749,230 | Direct | |
| Jun 24, 2025 | Common Stock | SSaleDisposed | −15,511 | $53.91 | −$836,198.01 | 733,719 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $8.11 | −$162,200 | 356,569 | Direct | |
| Jun 23, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $8.11 | −$162,200 | 336,569 | Direct | |
| Jun 24, 2025 | Common Stock | MOption exerciseDisposed | −20,000 | $8.11 | −$162,200 | 316,569 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.